Association of ABCC2 polymorphisms with platinum-based chemotherapy response and severe toxicity in non-small cell lung cancer patients.
about
Systems biology of cisplatin resistance: past, present and futureMatrix metalloproteinase-2 polymorphisms and clinical outcome of Chinese patients with nonsmall cell lung cancer treated with first-line, platinum-based chemotherapy.Heterozygote advantage of methylenetetrahydrofolate reductase polymorphisms on clinical outcomes in advanced non-small cell lung cancer (NSCLC) patients treated with platinum-based chemotherapy.RICTOR polymorphisms affect efficiency of platinum-based chemotherapy in Chinese non-small-cell lung cancer patients.Association of TERT Polymorphisms with Clinical Outcome of Non-Small Cell Lung Cancer Patients.Efflux transporter variants as predictors of drug toxicity in lung cancer patients: systematic review and meta-analysis.Chemotherapy-induced neutropenia during adjuvant treatment for cervical cancer patients: development and validation of a prediction model.Polymorphisms of p53 and MDM2 genes are associated with severe toxicities in patients with non-small cell lung cancer.Associations between ABCC2 polymorphisms and cisplatin disposition and efficacyAssociation between CASP8 and CASP10 polymorphisms and toxicity outcomes with platinum-based chemotherapy in Chinese patients with non-small cell lung cancerPolymorphic transporters and platinum pharmacodynamicsAssociations of genetic polymorphisms of the transporters organic cation transporter 2 (OCT2), multidrug and toxin extrusion 1 (MATE1), and ATP-binding cassette subfamily C member 2 (ABCC2) with platinum-based chemotherapy response and toxicity in nGenetic variants of GADD45A, GADD45B and MAPK14 predict platinum-based chemotherapy-induced toxicities in Chinese patients with non-small cell lung cancer.A prospective validation pharmacogenomic study in the adjuvant setting of colorectal cancer patients treated with the 5-fluorouracil/leucovorin/oxaliplatin (FOLFOX4) regimen.The P38α rs3804451 Variant Predicts Chemotherapy Response and Survival of Patients with Non-Small Cell Lung Cancer Treated with Platinum-Based Chemotherapy.The impact of drug transporters on adverse drug reaction.Pharmacogenomics of platinum-based chemotherapy sensitivity in NSCLC: toward precision medicine.Functional characterization of ABCC2 promoter polymorphisms and allele-specific expression.AGXT and ERCC2 polymorphisms are associated with clinical outcome in metastatic colorectal cancer patients treated with 5-FU/oxaliplatin.Genome-wide association study of myelosuppression in non-small-cell lung cancer patients with platinum-based chemotherapy.Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.
P2860
Q26863585-8C79671E-4321-4A3B-B10A-FBF68C278FE6Q33398142-F5B6B7B4-42B2-4C6B-BC7F-16FE4301A32CQ33416949-30D64F92-6120-454C-9303-8D4D03C1735BQ33435610-98F1AD6F-3AEA-4057-B823-8C76B394B4C6Q35644577-238196D5-C800-4085-BE96-25E65528CCBCQ36043023-5981AB5B-8DB6-4098-B7EC-E6FE8CC61409Q36046284-0F5D457E-9C64-4AB8-88CD-7D54C30A67DFQ36214773-BFD02228-174C-4537-9847-6013B5CACCEBQ36352809-32D6F2F3-8109-459F-9931-89AE4E6718F2Q36483179-3631C760-0FA0-410A-950C-3FB62BB77BB5Q36995742-48E7DAC0-E5F3-45DA-8F88-98DF85FD8BE5Q37230961-2F82D39E-03E7-4039-904E-8B232CA66E96Q37295316-753D849C-EFFB-4786-B20D-2147C095FE46Q37383249-2DD4690A-825D-47B4-9F41-A7C602F1608AQ37414070-8590C2A2-011E-4AC2-96D0-BB8660AFDE7AQ38075820-67AF5564-8957-49D2-B7E6-487C7DDEAD8EQ38909984-3609EC30-2C25-4EE6-9073-F1B47AE15030Q39337368-E42790EB-0E3F-4CC3-8103-9130C46FB106Q41495258-DF67B4D0-CCB4-48DF-9BA0-502F86C0C909Q47425743-9582A312-B746-489C-9F2D-A9C4F151D0B8Q48171906-DD1AC6DA-15D6-4CC5-AA76-2CC8303FAFD9
P2860
Association of ABCC2 polymorphisms with platinum-based chemotherapy response and severe toxicity in non-small cell lung cancer patients.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Association of ABCC2 polymorph ...... all cell lung cancer patients.
@ast
Association of ABCC2 polymorph ...... all cell lung cancer patients.
@en
type
label
Association of ABCC2 polymorph ...... all cell lung cancer patients.
@ast
Association of ABCC2 polymorph ...... all cell lung cancer patients.
@en
prefLabel
Association of ABCC2 polymorph ...... all cell lung cancer patients.
@ast
Association of ABCC2 polymorph ...... all cell lung cancer patients.
@en
P2093
P1433
P1476
Association of ABCC2 polymorph ...... all cell lung cancer patients.
@en
P2093
Baohui Han
Hongyan Chen
Jinchang Wu
Qingyi Wei
Wenting Wu
Xueying Zhao
P304
P356
10.1016/J.LUNGCAN.2010.09.001
P577
2010-10-12T00:00:00Z